is glp 1 safe for kidney disease GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes Glucagon-like Peptide-1 Receptor Agonists and

However, new research from Stanford Medicine suggests these drugs may not work equally well for everyone

Clinical trial data submitted to regulatory authorities, including the MHRA and European Medicines Agency (EMA), document headache as an adverse event across different GLP-1 medications, with varying frequencies depending on the specific drug and dosage

Physiologic and pathophysiologic roles of extra renal CYP27b1: case report and review

Now we need the evidence to catch up

AFMU = 5-acetyl-amino-6-formylamino-3-methyluracil

At the molecular level, resveratrol induces apoptosis through the activation of stress-responsive MAPK pathways (ERK, p38, and JNK), which phosphorylate and stabilize the tumor suppressor p53 at Ser15, enhancing its transcriptional activity [11,12,13]